The aim of this study is to evaluate the expression of cathepsin D in primary bladder cancer and to determine its relationship with conventional pathological features and serum cystatin C levels.
Methods
The immunohistochemical cathepsin D expression and staining patterns of epithelial and stromal cells were investigated in 21 patients with primary bladder carcinoma. Serum cystatin C levels were determined by immunoturbidimetry and compared with matched controls.
Results
There were 7 papillary neoplasms of low malignant potential, 7 low-grade and 7 high-grade carcinomas. Six tumors were invasive. Statistical analysis showed a significant inverse relationship between cathepsin D expression of the tumor cells and tumor grade and stage (P = 0.018 and P = 0.046, respectively). Serum cystatin C levels of the controls and patients varied between 0.39 mg/L and 1.99 mg/L (P >0.05). There was no significant relation between cathepsin D expression in tumor tissue and serum cystatin C levels.
Conclusions
Loss of cathepsin D expression in bladder carcinomas may be associated with high-grade and invasive tumors. Thus, increased cathepsin D expression by tumor cells may be related to local tumor invasion at an early stage, but it seems that extracellular cystatin C is not affected by cathepsin D expression of tumor or stromal cells, and cystatin C concentrations are not directly correlated with the progression of primary bladder carcinomas.
CalkinsC.C., SloaneB.F.: Mammalian cysteine protease inhibitors: Biochemical properties and possible roles in tumor progression.Biol Chem Hoppe Seyler, 376: 71–80, 1995.
4.
KirkaliG., TuzelE., GulerC., GezerS., KirkaliZ.: Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder.Eur Urol, 39: 292–299, 2001.
5.
RochefortH., CaponyF., GarciaM., CavaillesV., FreissG., ChambonM., MorissetM., VignonF.: Estrogen-induced lysosomal proteases secreted by breast cancer cells.A role in carcinogenesis? J Cell Biochem,35: 17, 1987.
6.
KristensenG.B., HolmR., AbelerV.M., TropeC.G.: Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma: An immunohistochemical study.Cancer, 78: 433–440, 1996.
7.
IoachimE., KaminaS., KontostolisM., AgnantisN.J.: Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer.Virchows Arch,431: 311–316, 1997.
8.
IoachimE., GoussiaA.C., MacheraM., TsianosE.V., KappasA.M., AgnantisN.J.: Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: A correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.Anticancer Res, 19: 2147–2156, 1999.
9.
GoussiaA., IoachimE., PeschosD., AssimakopoulosD., VougiouklakisT., SkevasA., AgnantisN.: Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices.Anticancer Res, 19: 3055–3060, 1999.
10.
IkeguchiM., SakataniT., UetaT., FukudaK., OkaS., HisamitsuK., YamaguchiK., TsujitaniS., KaibaraN.: Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma.J Clin Pathol, 55: 121–126, 2002.
11.
IoachimE., KitsiouE., CharalabopoulosK., MitselouA., ZagorianakouN., MakrydimasG., TziorasS., SalmasM.: Immunohistochemical evaluation of cathepsin D in normal, hyperplastic and malignant endometrium: correlation with hormone receptor status c-erbB-2, p53, Rb proteins and proliferation associated indices.Int J Gynecol Cancer, 13: 344–351, 2003.
12.
LindahlP., NycanderM., YlienjarviK., PolE., BjorkI.: Characterisation by rapid-kinetic and equilibrium methods of the reaction between N-terminally truncated forms of chicken cystatin and the cysteine proteinases papain and actinidin.Biochem J, 286: 165–171, 1992.
13.
BarrettA.J., FritzH., GrubbA., IsemuraS., JarvinenM., KatunumaN., MachleidtW., Muller-EsterlW., SasakiM., TurkV.: Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin.Biochem J,236: 311, 1986.
14.
KosJ., StabucB., SchweigerA., KrasovecM., CimermanN., Kopitar-JeralaN., VrhovecI.: Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.Clin Cancer Res;3: 1815–1822, 1997.
15.
KosJ., KrasovecM., CimermanN., NielsenH.J., Christensen IbJ., BrünnerN.: Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.Clin Cancer Res, 6: 505–511, 2000.
16.
BuckM.R., KarustisD.G., DayN.A., HonnK.V., SloaneB.F.: Degradation of extra-cellular matrix proteins by human cathepsin B from normal and tumor tissues.Biochem J, 282: 273–278, 1992.
17.
LenarcicB., KrasovecM., RiyonjaA., OlafssonI., TurkV.: Inactivation of human cystatin C and kininogen by human cathepsin D.FEBS Lett, 280: 211–215, 1991.
18.
IoachimE., CharchantiA., StavropoulosN., AthanassiouE., BafaM., AgnantisN.J.: Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices.Anticancer Res, 22: 3383–3388, 2002.
19.
DickinsonA.J., FoxS.B., NewcombP.V., PersadR.A., SibleyG.N., HarisA.L.: An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.J Urol, 154: 237–241, 1995.
20.
LipponenP.K.: Expression of cathepsin D in transitional cell bladder tumours.J Pathol, 178: 59–64, 1996.
21.
IuzimiT., IlyamaT., TanakaW., OkadaE., KamiyamaY., OkanoY., SatoS., YazakiT., UmedaT., ImamuraT.: Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder.Urol Int, 59: 81–87, 1997.
22.
ÖzerE., MunganM.U., TunaB., KazimoĝluH., YörükoĝluK., KırkalıZ.: Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer.Urology, 54: 50–55, 1999.
23.
Carrascosa LloretC., Cremades MiraA., Sanchez SanchisM., Rodrigo GuanterV., Beltran ArmadaJ.R., Sala AznarA., Vacacela CordovaR., Coronel SanchezB., Clar BlanchF., Tarin PlanesM., Sanjuan de LaordenC.: Study of cathepsin D levels in invasive bladder cancer and its stroma.Correlation with tumor stage, cytological grade, lymph node metastasis and survival. Actas Urol Esp, 26: 335–382, 2002.
24.
NewmanD.J., ThakkarH., EdwardsR.G., WilkieM., WhiteT., GrubbA.O., PriceC.P.: Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes of GFR than serum creatinine.Kidney Int, 47: 312–318, 1995.
25.
SauterG., AlgabaF., AminM.B., BuschC., ChevilleJ., GassaerT., GrignonD.J., HofstädterF., Lopez-BeltranA., EpsteinJ.I.: Non-invasive urothelial tumours. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs,EbleJ.N., SauterG., EpsteinJ.I., SesterhennI.A. (Eds), p 110, IARC Press, Lyon, 2004.
26.
LiottaL.A.: Tumor invasion and metastases: Role of the basement membrane.Am J Pathol,117: 339, 1984.
27.
OkamotoH., GreenbaumL.M.: Kininogen substrates for trypsin and cathepsin D in human, rabbit and rat plasmas.Life Sci, 32: 2007–2013, 1983.
28.
LenarcicB., KosJ., DolencI., LucovnikP., KrizajI., TurkV.: Cathepsin D inactivates cysteine proteinase inhibitors, cystatins.Biochem Biophys Res Commun, 154: 765–772, 1988.
29.
DomejW., TilzG.P., Foldes-PappZ., DemelU., RaboldT., HolzerH.: Cystatin C of pleural effusion as a novel diagnostic aid in pleural diseases of different aetiologies.Clin Sci, 102: 373–380, 2002.
30.
StrojanP., SveticB., SmidL., KosJ.: Serum cystatin C in patients with head and neck carcinoma.Clin Chim Acta, 344: 155–161, 2004.
31.
FinneyH., WilliamsA.H., PriceC.P.: Serum cystatin C in patients with myeloma.Clin Chim Acta, 309: 1–6, 2001.
32.
TakeuchiM., FukudaY., NakanoI., KatanoY., HayakawaT.: Elevation of serum cystatin C concentrations in patients with chronic liver disease.Eur J Gastroenterol Hepatol, 13: 951–955, 2001.
33.
KosJ., LahT.T.: Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review).Oncol Rep, 5: 1349–1361, 1998.
